Skip to main navigation Skip to search Skip to main content

Cybersecurity in Artificial Pancreas Experiments

  • Derek T. O'Keeffe
  • , Spyridoula Maraka
  • , Ananda Basu
  • , Patrick Keith-Hynes
  • , Yogish C. Kudva
  • Mayo Clinic
  • University of Virginia School of Medicine

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

34 Citations (Scopus)

Abstract

Medical devices have transformed modern health care, and ongoing experimental medical technology trials (such as the artificial pancreas) have the potential to significantly improve the treatment of several chronic conditions, including diabetes mellitus. However, we suggest that, to date, the essential concept of cybersecurity has not been adequately addressed in this field. This article discusses several key issues of cybersecurity in medical devices and proposes some solutions. In addition, it outlines the current requirements and efforts of regulatory agencies to increase awareness of this topic and to improve cybersecurity.

Original languageEnglish
Pages (from-to)664-666
Number of pages3
JournalDiabetes Technology and Therapeutics
Volume17
Issue number9
DOIs
Publication statusPublished - 1 Sep 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Cybersecurity in Artificial Pancreas Experiments'. Together they form a unique fingerprint.

Cite this